Skip to main content
Clinical Trials/NL-OMON54037
NL-OMON54037
Recruiting
Not Applicable

Identification and characterization of non-alcoholic fatty liver disease in primary care. - NAFLD primary care

niversiteit Maastricht0 sites1,468 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
1,468

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational invasive

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Able to understand and sign the informed consent
  • Able to speak Dutch
  • Between 18\-80 years
  • BMI \>25 kg/m²
  • Having one of the following conditions: 1\)overweight, 2\) obesity, 3\) type 2
  • diabetes mellitus, 4\) cardiovascular diseases (hypertension, atherosclerosis,
  • angina pectoris, ischaemic heart condition, cerebrovascular condition)
  • Additional inclusion criteria valid only for the other food additives and
  • limonene breath test
  • All those listed in the main protocol \+

Exclusion Criteria

  • Excessive alcohol use
  • o more than 20 g/day for women and 30g/day for men
  • o \>2 glasses alcohol/day for women and \>3 glasses for men
  • Other liver diseases: Hepatitis B virus, Hepatitis C virus, autoimmune
  • hepatitis, primary biliary cirrhosis, hemochromatosis, Wilson\*s disease, Alpha
  • 1 antitrypsin deficiency
  • Secondary causes for steatosis: disorders of lipid metabolism, HCV Genotype 3,
  • total parental nutrition, severe surgical weight loss, medications (amiodarone,
  • tamoxifen, methotrexate, corticosteroids and HAART), lean steatosis, Celiac
  • disease, environmental toxicity

Investigators

Similar Trials